Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T1622 The Registry Study of Genetic Alterations of Melanoma in Taiwan

NCT06952400 is registered in ClinicalTrials.gov with National Health Research Institutes, Taiwan as lead sponsor.

NCT NCT06952400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06952400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T1622 The Registry Study of Genetic Alterations of Melanoma in Taiwan
Lead sponsor
National Health Research Institutes, Taiwan
Phase
Observational
Overall status
Recruiting
Start date
August 22, 2022
Completion date
December 31, 2030
Enrollment
250 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

primary melanoma of the extremity